Oxford Asset Management’s Regenxbio RGNX Stock Holding History

Oxford Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6,600	Closed	-$378K	–	1917
2019 Q1	$378K	Buy	+6,600	New	+$327K	0.01%	1342
2018 Q4	–	Sell	-6,580	Closed	-$505K	–	2045
2018 Q3	$505K	Buy	+6,580	New	+$474K	0.01%	1309
2018 Q2	–	Sell	-31,798	Closed	-$949K	–	1887
2018 Q1	$949K	Buy	+31,798	New	+$925K	0.02%	963
2017 Q2	–	Sell	-10,698	Closed	-$206K	–	1664
2017 Q1	$206K	Buy	+10,698	New	+$206K	0.01%	1307
2016 Q1	–	Sell	-14,642	Closed	-$243K	–	881
2015 Q4	$243K	Buy	+14,642	New	+$291K	0.01%	776

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Oxford Asset Management's RGNX Position: Q2 2019 in Review

Oxford Asset Management sold out of Regenxbio (RGNX) in Q2 2019, closing a stake of 6,600 shares — an estimated $378K sold.

Oxford Asset Management first reported a position in RGNX in Q4 2015 and held it in 5 quarters. The position peaked at $949K in Q1 2018. 186 funds tracked by Wall St. Rank hold RGNX as of Q2 2019.

Oxford Asset Management reported no remaining Regenxbio position as of Q2 2019 after selling out during the quarter.
Oxford Asset Management sold 6,600 Regenxbio shares in Q2 2019, an estimated $378K.
Oxford Asset Management first reported a position in Regenxbio in Q4 2015 and held it in 5 quarters.
Oxford Asset Management's Regenxbio position peaked at $949K in Q1 2018.
186 funds tracked by Wall St. Rank held Regenxbio as of Q2 2019.

Based on Oxford Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.